![]() ![]() ![]() Patients treated with dabigatran have underlying disease states that predispose them to thromboembolic events reversing dabigatran therapy exposes patients to the thrombotic risk of their underlying disease to reduce this risk, resume anticoagulant therapy as soon as medically appropriate ![]()
0 Comments
Leave a Reply. |